Meta facebook tracking pixel

Past Workshops

  1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 48th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 48th Annual San Antonio Breast Cancer Symposium
  2. Updates from the 48th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
  3. Updates from the 48th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer – Updates from the 48th Annual San Antonio Breast Cancer Symposium
  4. For Caregivers: Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart II of Living with Triple Negative Breast Cancer
  5. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Triple Negative Breast Cancer
  6. Triple Negative Breast Cancer and African American Women
  7. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  8. Updates from the 2025 American Society of Clinical Oncology (ASCO) Annual Conference on Triple Negative Breast Cancer
  9. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
  10. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life
  11. Metastatic Breast Cancer: Treatment Updates
  12. Understanding HER2 Low Breast Cancer
  13. Breast Cancer in Younger Women: New Treatment Options
  14. Breast Cancer in Men: Diagnosis, Treatment and Survivorship
  15. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer
  16. Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer
  17. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  18. Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
  19. For Caregivers: Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
  20. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
  21. Triple Negative Breast Cancer and African American Women
  22. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  23. Updates from the American Society of Clinical Oncology (ASCO) 2024 on Triple Negative Breast Cancer
  24. Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
  25. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
  26. Breast Cancer in Younger Women: New Treatment Options
  27. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
  28. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  29. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
  30. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  31. Lobular Breast Cancer: Treatment Progress
  32. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
Back to Top